(1R,1'R)-1,1'-((4S,5S)-2,2-dimethyl-1,3-dioxolane-4,5-diyl)bis(2-phenylethanamine) | 170870-15-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (1R,1'R)-1,1'-((4S,5S)-2,2-dimethyl-1,3-dioxolane-4,5-diyl)bis(2-phenylethanamine)
• 英文别名: (2R,3S,4S,5R)-2,5-Diamino-1,6-diphenyl-3,4-(1-methylethylidene)bis(oxy)hexane；(1R)-1-[(4S,5S)-5-[(1R)-1-amino-2-phenylethyl]-2,2-dimethyl-1,3-dioxolan-4-yl]-2-phenylethanamine
• CAS: 170870-15-2
• 化学式: C₂₁H₂₈N₂O₂
• 分子量: 340.466
• InChiKey: DWYGCNIREGQVDY-ZRNYENFQSA-N

物化性质

• 沸点：
  479.4±30.0 °C(Predicted)
• 密度：
  1.101±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.7
• 重原子数：
  25
• 可旋转键数：
  6
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.43
• 拓扑面积：
  70.5
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  (1R,1'R)-1,1'-((4S,5S)-2,2-dimethyl-1,3-dioxolane-4,5-diyl)bis(2-phenylethanamine) 在 盐酸 作用下， 以 水 为溶剂， 反应 3.0h， 生成 (2R,3S,4S,5R)-2,5-diamino-1,6-diphenylhexane-3,4-diol
  参考文献：
  名称：

  Grignard Addition to Aldonitrones. Stereochemical Aspects and Application to the Synthesis of C₂-Symmetric Diamino Alcohols and Diamino Diols

  摘要：

  A new example of the stereoselective installation of the amino group at a saturated carbon center via organometallic addition of chiral aldehydes to nitrones is illustrated by the synthesis of 1,3-diamino propanol 1 and 1,4-diamino butandiol 2 units. Three diamino alcohol 1 stereotriads were obtained by stereoselective addition of alkylmagnesium halides (benzyl, cyclohexylmethyl, and metallyl) to the N-benzyl nitrones derived from beta-amino-alpha-hydroxy aldehydes followed by reduction of the resulting N-benzylhydroxylamines. Three 1,4-dibenzyl substituted stereoisomers of type 2 with fixed S configuration at C2 and C3 were prepared by sequential and simultaneous amination in two directions starting from L-threose nitrone and L-tartraldehyde bis-nitrone, respectively. The R,S,S,R isomer obtained by the former route was converted into a seven-membered ring cyclic urea (1,3-diazapin-2-one), i.e., a compound that belongs to a class of nonpeptide HIV-1 protease inhibitors.

  DOI：

  10.1021/jo980980u
• 作为产物：
  描述：

  (2R,3S,4S,5R)-2,5-bis[N-(benzyloxycarbonyl)amino]-1,6-diphenyl-3,4-hexanediol 在 20 % Pd(OH)2/C 、 camphor-10-sulfonic acid 、 环己烯 作用下， 以 乙醇 、 二氯甲烷 为溶剂， 生成 (1R,1'R)-1,1'-((4S,5S)-2,2-dimethyl-1,3-dioxolane-4,5-diyl)bis(2-phenylethanamine)
  参考文献：
  名称：

  官能化二胺二醇羰基化为环状脲：在DMP 450衍生物中的应用

  摘要：

  HIV蛋白酶抑制剂DMP 450的环状脲核心结构的合成已经通过W（CO）6 / I 2催化的二胺中间体的羰基化而实现。还检查了相关的官能化二胺羰基化为DMP 450核心结构的衍生物。选定的二胺二醇底物可通过催化羰基化转化为环状脲核心结构，而无需保护二醇的功能。

  DOI：

  10.1016/j.tet.2011.04.015

文献信息

• Stereoisomers of Cyclic Urea HIV-1 Protease Inhibitors:  Synthesis and Binding Affinities
  作者：Robert F. Kaltenbach、David A. Nugiel、Patrick Y. S. Lam、Ronald M. Klabe、Steven P. Seitz

  DOI：10.1021/jm980255b

  日期：1998.12.1

  We have synthesized stereoisomers of cyclic urea HIV-1 protease inhibitors to study the effect of varying configurations on binding affinities. Four different synthetic approaches were used to prepare the desired cyclic urea stereoisomers. The original cyclic urea synthesis using amino acid starting materials was used to prepare three isomers. Three additional isomers were prepared by synthetic routes

  我们已经合成了环状脲HIV-1蛋白酶抑制剂的立体异构体，以研究各种构型对结合亲和力的影响。使用四种不同的合成方法来制备所需的环状脲立体异构体。使用氨基酸起始原料的原始环状脲合成用于制备三种异构体。通过使用L-酒石酸和D-山梨糖醇作为手性原料的合成路线制备了三种另外的异构体。环状脲反式二醇的立体选择性羟基转化用于制备三种另外的异构体。共准备了10种可能的全部9种环状脲立体异构体，并描述了它们的结合亲和力。
• Catalytic enantioselective synthesis of secondary alcohols using C2-symmetric diamino diol ligands
  作者：Biao Jiang、Yan Feng、Jian-Feng Hang

  DOI：10.1016/s0957-4166(01)00409-8

  日期：2001.9

  A new class of diamino diols was evaluated as catalytic ligands in the enantioselective borane reduction of aromatic ketones and the enantioselective ethylation of arylaldehydes with diethylzinc. By variation of the substitution pattern on the ketone, e.e.s of up to 94% could be obtained by in situ borane reduction using 0.025 equiv. of the ligand at 35°C in THF. N,N,N′,N′-Tetramethyldiamino diol and

  评估了一类新型的二氨基二醇作为芳族酮的对映选择性硼烷还原和芳醛与二乙基锌的对映选择性乙基化的催化配体。通过改变酮上的取代模式，可通过使用0.025当量的原位硼烷还原获得高达94％的ee。35℃下的配体在THF中的摩尔数。N，N，N ′，N′-四甲基二氨基二醇和N，N′-二烷基二氨基二醇用作促进剂，用于将二乙基锌试剂对映选择性地添加到芳醛中，其中使用0.1当量。的Ñ，Ñ，Ñ '，Ñ在将二乙基锌添加到芳醛中时，以'-四甲基二氨基二醇为催化剂可实现高达98％的ee。
• Synthesis of unsymmetric cyclic urea diols, a novel class of HIV protease inhibitors
  作者：Benjamin R.P. Stone、Gregory D. Harris、Reginald O. Cann、Thomas E. Smyser、Pat N. Confalone

  DOI：10.1016/s0040-4039(98)01263-5

  日期：1998.8

  Unsymmetric cyclic urea diols of general structure 1 can be prepared either via an isourea derived from the symmetric diamine 2 or by the selective removal of a benzyl group from certain symmetric cyclic ureas 8, employing dissolving metal reduction.

  通式1的不对称环状脲二醇可以通过衍生自对称二胺2的异脲或通过使用溶解性金属还原从某些对称环状脲8中选择性地除去苄基来制备。
• Synthesis, antiviral activity and pharmacokinetics of P1/P1′ substituted 3-aminoindazole cyclic urea HIV protease inhibitors
  作者：Robert F Kaltenbach、Mona Patel、Robert E Waltermire、Gregory D Harris、Benjamin R.P Stone、Ronald M Klabe、Sena Garber、Lee T Bacheler、Beverly C Cordova、Kelly Logue、Matthew R Wright、Susan Erickson-Viitanen、George L Trainor

  DOI：10.1016/s0960-894x(02)01064-8

  日期：2003.2

  A series of P1/P1' substituted cyclic urea analogues were prepared in an attempt to increase the intra-cellular antiviral potency of the nonsymmetrical 3-aminoindazoles DMP 850 and DMP 851. The effect of alkyl substitution of the P1/P1' residues on cellular antiviral potency, protein binding, resistance profile and pharmacokinetics are described.

  制备了一系列P1 / P1'取代的环状脲类似物，以试图提高非对称3-氨基吲唑DMP 850和DMP 851的细胞内抗病毒效力。P1 / P1'残基的烷基取代对细胞的影响描述了抗病毒效力，蛋白结合，抗药性和药代动力学。
• Method for preparing cyclic sulfamides and their use for the synthesis
  申请人：The Du Pont Merck Pharmaceutical Company

  公开号：US05506355A1

  公开（公告）日：1996-04-09

  The present invention discloses processes for the preparation of substituted cyclic sulfamides which are useful as intermediates for the synthesis of cyclic sulfamide human immunodeficiency virus (HIV) protease inhibitors. Such substituted cyclic sulfamide intermediates contain a cyclic acetal-protected diol.

  本发明公开了制备替代环磺酰胺的方法，这些方法可用作合成环磺酰胺人类免疫缺陷病毒（HIV）蛋白酶抑制剂的中间体。这些替代环磺酰胺中间体包含一个环缩醛保护的二醇。